Niagen Bioscience Inc (NAGE)

R&D Expense Growth

2.16%

Quarterly · Period ending:

NAGE logo

NAGE R&D Expense Growth

Latest reported2.16%
NAGE Quarterly R&D Growth (QoQ) (0.00% → 2.16%)
High-resolution chart · PNG

NAGE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
2.1607%
-13.3918%
-4.7354%
14.5501%
24.5628%
-4.3346%
1.938%
-1.9757%
-37.1838%
80.7593%
-6.6076%
-9.0842%
14.4174%
-6.724%
4.4935%
-1.6867%
15.4917%
3.1579%
4.9197%
-0.7968%
27.5731%
-20.5853%
17.8359%
-6.0335%
-2.6115%
-19.3152%
9.0996%
-2.3386%
-8.476%
-8.3922%
-5.5556%
-4.5262%
-1.7373%
-0.9409%
39.6796%
22.3529%
28.012%
24.3048%
-30.8784%
2.8033%
61.9848%
0%
-100%
7.5708%
44.8532%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.